Novartis Investigative Site
Hlučín, Czech Republic 748 01
0 studies enrolling now · 1 studies all time
What they study most
Arthritis, Psoriatic
Studies at this site
16-week Efficacy and 2-year Safety, Tolerability and Efficacy of Secukinumab in Participants With Active Psoriatic Arthritis
— Completed